These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 4888031

  • 1. Suppression of the corneal homograft reaction by antilymphocyte serum.
    Smolin G.
    Arch Ophthalmol; 1969 Apr; 81(4):571-6. PubMed ID: 4888031
    [No Abstract] [Full Text] [Related]

  • 2. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR, Faulkner HW, Burde RM.
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract] [Full Text] [Related]

  • 3. Suppression of corneal graft reaction by antilymphocyte serum. 3. Effect of pretreatment of donor animals.
    Smolin G, Hyndiuk RA.
    Arch Ophthalmol; 1971 Apr; 85(4):451-4. PubMed ID: 4929072
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Corneal homograft reaction following subconjunctival antilymphocyte serum.
    Smolin G.
    Am J Ophthalmol; 1969 Jan; 67(1):137-9. PubMed ID: 4882563
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Superiority of antithymus serum to antilymphocyte serum in prolonging cardiac homograft survival.
    Lueker RD, Ono K, Lueker DC.
    Proc Soc Exp Biol Med; 1971 May; 137(1):139-41. PubMed ID: 4932045
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of corneal graft reaction by antilymphocyte serum.
    Smolin G.
    Arch Ophthalmol; 1968 May; 79(5):603-10. PubMed ID: 4868991
    [No Abstract] [Full Text] [Related]

  • 9. Biological effects of antithymus serum and antilymphocyte serum.
    Nagaya H, Sieker HO.
    Prog Immunobiol Stand; 1970 May; 4():225-9. PubMed ID: 4098263
    [No Abstract] [Full Text] [Related]

  • 10. Modification of corneal homograft rejection by donor pretreatment with antilymphocyte serum.
    Lernor RE, Burde RM, Waltman SR.
    Am J Ophthalmol; 1970 Mar; 69(3):453-7. PubMed ID: 4392176
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mode of action of antilymphocyte serum.
    DeMeester TR.
    Surg Gynecol Obstet; 1969 Oct; 129(4):717-22. PubMed ID: 4898242
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Homograft rejection delayed by treatment of donor tissue in vitro with antilymphocyte serum.
    Burde RM, Waltman SR, Berrios JH.
    Science; 1971 Sep 03; 173(4000):921-3. PubMed ID: 4937230
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Testing of antihuman lymphocyte sera in chimpanzees and lower primates.
    Balner H, Dersjant H, Van Bekkum DW.
    Transplantation; 1969 Sep 03; 8(3):281-90. PubMed ID: 4985395
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.